Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Long-Term Debt Repayments (2024 - 2025)

OptimizeRx's Long-Term Debt Repayments history spans 2 years, with the latest figure at $500000.0 for Q3 2025.

  • For Q3 2025, Long-Term Debt Repayments changed 0.0% year-over-year to $500000.0; the TTM value through Sep 2025 reached $8.0 million, up 433.33%, while the annual FY2024 figure was $4.0 million, 133.92% up from the prior year.
  • Long-Term Debt Repayments for Q3 2025 was $500000.0 at OptimizeRx, down from $4.5 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $4.5 million in Q2 2025 and bottomed at $500000.0 in Q1 2024.